High dose-rate versus low dose-rate brachytherapy for lip cancer

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 4, 2012, Pages 1205-1212

  Ghadjar, Pirus ^a   Bojaxhiu, Beat ^a   Simcock, Mathew ^b   Terribilini, Dario ^a   Isaak, Bernhard ^a   Gut, Philipp ^a   Wolfensberger, Patrick ^a   Brömme, Jens O ^a   Geretschläger, Andreas ^a   Behrensmeier, Frank ^a   Pica, Alessia ^a   Aebersold, Daniel M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

Author keywords

Brachytherapy; High dose rate; Lip cancer; Low dose rate

Indexed keywords

ADVERSE EVENTS; BRACHYTHERAPY; COMMON TERMINOLOGY CRITERIA; DOSE-RATE; HDR BRACHYTHERAPY; HIGH DOSE RATE; HIGH-DOSE-RATE BRACHYTHERAPY; LDR BRACHYTHERAPY; LIP CANCER; LOCOREGIONAL CONTROL; LOW DOSE; LOW DOSE RATE; OVERALL SURVIVAL RATES; RECURRENCE-FREE SURVIVAL; SQUAMOUS CELL CARCINOMA;

DISEASES; ONCOLOGY; TOXICITY;

RADIOTHERAPY;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER SURGERY; DOSE RESPONSE; DOSE VOLUME HISTOGRAM; FEMALE; FOLLOW UP; HIGH DOSE RATE BRACHTHERAPY; HISTOGRAM; HUMAN; INTERMETHOD COMPARISON; LATE TOXICITY; LIP CARCINOMA; LOW DOSE RATE BRACHYTHERAPY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TOXICITY;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIP NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SWITZERLAND; TUMOR BURDEN;

EID: 84862684888     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.09.038     Document Type: Article

References (12)

1. Beauvois S, Hoffstetter S, Peiffert D, et al. Brachytherapy for lower lip epidermoid cancer: Tumoral and treatment factors influencing recurrences and complications. Radiother Oncol 1994;33:195-203.
2. Gerbaulet A, Pötter R, Mazeron JJ, et al. The GEC ESTRO handbook of brachytherapy. Brussels: ESTRO; 2002.
3. Guibert M, David I, Vergez S, et al. Brachytherapy in lip carcinoma: Long-term results. Int J Radiat Oncol Biol Phys. In press.
4. Guinot JL, Arribas L, Chust ML, et al. Lip cancer treatment with high dose rate brachytherapy. Radiother Oncol 2003;69:113-115.
5. Gerbaulet A, Maher M. Brachytherapy in the treatment of head and neck cancer. In: Joslin CAF, Flynn A, Hall ES, editors. Principles and practice of brachytherapy using afterloading systems. New York: Arnold; 2001. p. 284-295.
6. Mazeron JJ, Ardiet JM, Haie-Méder C, et al. GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol 2009;91:150-156.
7. Baltas D, Kolotas C, Geramani K, et al. A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys 1998;40:515-524.
8. Saw CB, Suntharalingam N. Quantitative assessment of interstitial implants. Int J Radiat Oncol Biol Phys 1991;20:135-139.
9. De Visscher JG, van den Elsaker K, Grond AJ, et al. Surgical treatment of squamous cell carcinoma of the lower lip: Evaluation of long term results and prognostic factors. A retrospective analysis of 184 patients. J Oral Maxillofac Surg 1998;56:814-820.
10. Vukadinovic M, Jezdic Z, Petrovic M, et al. Surgical management of squamous cell carcinoma of the lip: Analysis of a 10-year experience in 223 patients. J Oral Maxillofac Surg 2007;65:675-679.
11. Cerezo L, Liu FF, Tsang R, Payne D. Squamous cell carcinoma of the lip: Analysis of the Princess Margaret Hospital experience. Radiother Oncol 1993;28:142-147.
12. Mazeron JJ, Simon JM, Le Péchoux C, et al. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinoma of mobile tongue and floor of mouth with interstitial iridium 192. Radiother Oncol 1991;21:39-47.